Replication-incompetent adenovirus vector-mediated MDA-7/IL-24 selectively induces growth suppression and apoptosis of hepatoma cell Line SMMC-7721

Abstract

In order to investigate the effect of replication-incompetent adenovirus vector expressing MDA-7/IL-24 on tumor growth and apoptosis of human hepatocellular carcinoma (HCC) cell line SMMC-7721 and normal liver cell line L02, the recombinant replication-incompetent Ad.mda-7 virus vector was constructed and infected into the HCC cell line SMMC-7721 and normal liver cell line L02. RT-PCR was performed to examine the expression of MDA-7 mRNA. The concentrations of MDA-7/IL-4 in culture supernatants were determined by using ELISA. MTT and Hoechst staining assay were applied to observe the inhibitory and killing effects of MDA-7 on the HCC cells. By using flow cytometry, the apoptosis, cell cycle and proliferation of SMMC-7721 and L02 cells were measured. The results showed recombinant replication-incompetent virus expressing MDA-7/IL-24 was constructed successfully, and RT-PCR revealed that it could mediate the high expression of the exogenous gene MDA-7/IL-24 in SMMC-7721 and L02 cells. The expression of MDA-7/IL-24 proteins in the culture supernatant was detectable by ELISA. Ad.mda-7 infection induced apoptosis and growth suppression in SMMC-7721 cells and an increased percentage of HCC cells in the G₂/M phase of the cell cycle, but not in L02 cells. It was concluded that mda-7/IL-24 gene, mediated with replication-incompetent adenovirus vector, could selectively induce growth suppression and apoptosis in HCC cell line SMMC-7721 but without any toxic side-effect on normal liver line L02.

Keywords

cancer gene therapy / hepatocellular carcinoma / apoptosis / growth suppression / MDA-7/IL-24

References

[1] VenookA. P.. Treatment of hepatocellular carcinoma: too many options?. J Clin Oncol, 1994, 12(6): 1323-1334

[2] LebedevaI. V., SauaneM., GopalkrishnanR. V., et al.. Mda-7/IL-24: Exploiting Cancer’s Achilles’ Heel. Mol Ther, 2005, 11(1): 4-18

[3] JiangH., LinJ. J., SuZ. Z., et al.. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 1995, 11(12): 2477-2486

[4] HuangE. Y., MadireddiM. T., GopalkrishnanR. V., et al.. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene, 2001, 20(48): 7051-7063

[5] GopalkrishnanR. V., SauaneM., FisherP. B.. Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24. Int Immunopharmacol, 2004, 4(5): 635-647

[6] SarkarD., SuZ. Z., LebedevaI. V., et al.. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. PNAS, 2002, 99(15): 10 054-10 059

[7] KawabeS., NishikawaT., MunshiA., et al.. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther, 2002, 6(5): 637-644

[8] McKenzieT., LiuY., FanaleM., et al.. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery, 2004, 136(2): 437-442

[9] LebedevaI. V., SuZ. Z., SarkarD., et al.. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene, 2005, 24(4): 585-596

[10] SuZ. Z., LebedevaI. V., SarkarD., et al.. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53 independent manner. Oncogene, 2003, 22(8): 1164-1180

[11] LebedevaI. V., SuZ. Z., SarkarD., et al.. Melanoma differentiation associated gene-7, mda-7/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res, 2003, 63(23): 8138-8144